Type 2 Diabetes Mellitus (Eluminate-2)
Type 2 Diabetes Mellitus (T2DM)
Study information:
Condition: Type 2 Diabetes Mellitus (T2DM)
Location: Albuquerque, New Mexico
Duration: Up to 54 weeks
Participation: Up to 12 visits
Compensation: Available
Eligibility:
18 years or older
Diagnosed with T2DM
Other study requirements apply.
Participants may receive:
Compensation
Regular check-ins with a team of doctors and nurses to monitor your health
All study-related care and medications will be provided at no cost
Some participants will receive placebo, which will have no effect on their condition
Get started today.
You are not committed to participate in a study by completing this form. Participation is voluntary, and you may leave at any time if you change your mind.
What is Type 2 Diabetes Mellitus (T2DM)?
Type 2 Diabetes Mellitus is….
The T2DM study is sponsored by Astra-Zeneca and all information is provided by Astra-Zeneca.

